Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The good news is they will have to get the share price north of $.30 to get all of the warrants exercised;)
Sun Spotted the Salaries....What did they do?
"On March 30, 2011, our total cash and cash equivalents was approximately $2,500,000. As a result we believe we have sufficient resources to meet all of our current obligations."
So..., Only 2.5 mil left!
I will say that Dr.B has earned his salary & bonus and will probably forgive him for letting ST and TG go out the door with all that cash and stock if the company can get by as follows:
"The Company believes it currently has sufficient cash to support operations until it is able to generate revenue through royalty payments from the molecular diagnostic deals signed, revenue generation from the melanoma risk assessment and additional new licensing fees from its significant patent portfolio and development fees for providing services related to those patents. In addition, the Company has been and continues to be in meaningful discussions with a variety of parties related to the commercialization efforts discussed above, which if successful, may result in significant revenue."
However, if the events mentioned above don't materialize in the "Very Near Future",... look out for this:
"Should it prove necessary, the Company may also consider such alternatives as raising additional equity through private placements and/or debt offerings."... at which point I will say we got ripped:(
Patent Enforcement Strategy Revealed!
"The Company plans to initiate its new academic/research institution licensing program in the second quarter of 2011. Universities and research institutions that have reported the use of SVMs in published reports such as academic journals and conference proceedings will be contacted and offered a paid-up license against past and future infringement of the Company’s patented technology for a nominal one-time license administrative fee plus a percentage of any revenue generated when the results of the SVM usage are licensed for commercialization. The program will begin first with admitted usages of the Company’s SVM-RFE method. To date, over 30 U.S. institutions have been identified as using RFE through review of academic publications, with many of the reported uses relating to biomarker discovery and medical diagnostics. The Company plans to expand its licensing efforts to European institutions once all formalities have been completed for validation of the recently-granted European SVM-RFE patent. The program will later be broadened to other reported uses of SVM and other technology covered by the Company’s patents."
SVM Capital Alive!
"Atlantic Alpha is now exclusively trading SVM's K-2 model and will begin offering this technology to the public via a new fund which began trading in January 2011. HDC owns a 45% equity position in SVM Capital."
Looks like PMCP,LP sold their entire position before 12/31/10.
Here are the current Top Institutional Holders:
ACADEMY CAPITAL MANAGEMENT
CONESTOGA CAPITAL ADVISORS
PENN MUTUAL LIFE INSURANCE CO
Janney Montgomery Scott
Geduld, Emanuel, E.
CRAWFORD INVESTMENT COUNSEL, INC.
WESBANCO BANK INC.
I wonder how they liquidated it and who the buyer was. Please correct me if I'm wrong.
Wasn’t that supposed to be launched down under because the Aussie’s have the highest incidence of Melanoma and it would be in time for the summer...., or was it for next summer?
Quest up nicely today. Got this from the 8K:
“We have taken actions to strengthen our sales organization, expand our pipeline of new tests and services, and improve our operating efficiency, which position us for revenue and EPS growth.”
Anyone listen to the conference call or hear anything else?
Rumor has it that Dr. B is very upset about the commercialization delays. No one has seen or heard from him since he left for Vegas with his bonus to personally validate the brand new Blackjack SVM IPOD APP(BSVM). Don’t expect to hear about the test results anytime soon because as we all know; “What happens in Vegas stays in Vegas”.
Should see it in the very near future;)
Rapid fire now... taking blocks at $0.17!! ;)
Agreed. Looks like a 250K block went through. Maybe Dr. B has been out and about and may have mentioned that he expects things to happen in the very near future.
King, If Quest has no immediate plans to develop and offer the test, I wonder if we should call and ask if they could develop and offer it in the very near future?
FWIW: DGX at a 6 month high, EOM
Chazzy, The intro. is awesome! Thank you.
Thank you for the effort. Can I suggest listing the recent 8K and S1 filings as "SEC Filings", not "Press Releases"? For "Current Deals", suggest a link to the shareholder letter: http://www.healthdiscoverycorp.com/pr.php#
MELA's woes maybe the cause for recent weakness.
http://www.minyanville.com/businessmarkets/articles/mela-sciences-fda-skin-cancer-melanoma/11/16/2010/id/31168?camp=syndication&medium=portals&from=yahoo
Don't recall seeing this before but I like it:
"We are also developing platforms to allow for the integration of clinical, pathological and radiological data to advance the goal of personalized medicine, among other activities," said Dr. Barnhill.
Check this out
http://www.cancerforums.net/threads/14245-New-Early-Detection-Test
This same guy 'Fairwind' has posted information on the WebMD-Forum. Stating that this test is coming out in a few months.
The above posted by "KAMMKR" on the Yahoo board.
Would appreciate hearing what Tom's vision was knowing that plans for a share buy back may indicate much more prosperous times ahead than if they were considering a reverse split. Thanks in advance.
I believe it means they now own the license but to early to tell if they will use it. Maybe Zenos can comment on that.
Mr. Gallagher went on to become a Vice President at Goldman, Sachs & Co. (NYSE: GS - News), New York, NY, where he assisted numerous companies in strategic buy backs of their stock.
From the agreement with Clarient:
"ARTICLE XI. ASSIGNABILITY
A. Neither this Agreement nor the rights or licenses herein granted shall be assignable or otherwise transferable by either party without the prior written consent of the other party; provided, however, that either party may assign this Agreement in connection with the transfer or sale of its business or all or substantially all of its assets or stocks or in the event of a merger, consolidation, change in control or similar corporate transaction, without such consent.
Agree and like the fact that we are now connected to another big player in the space.
Agree and like the fact that we are now connected to another big player in the space.
GE Healthcare to Acquire Cancer Diagnostic Company Clarient
http://www.triggernews.com/prnewswire/20101022/LA86865.html
Dr. Barnhill was the founder and CEO of the Barnhill Clinical Laboratories, which was acquired by Quest Diagnostics.
An end to the Dirty Laundry News???
http://finance.yahoo.com/news/R-Scott-Tobin-Steps-Down-from-bw-4099872207.html?x=0&.v=1
Lets hope so.
Still waiting for the following as mentioned in the Shareholder Letter dated 8/26/10:
(1)"We expect to choose our partner for the development and commercialization of this new molecular diagnostic test for pancreatic cancer in the very near future."
(2)"We expect to choose our partner/partners for the development and commercialization of this new molecular diagnostic test for colon cancer in the very near future."
Not sure exactly what he did to create shareholder value but looks like he was really good at cutting a deal that gave him access to a ton of stock and cash at the shareholders expense.
Rec'd the proxy package today. Adding Curtis G. Anderson to the board and selecting the same accounting firm. Received with a copy of the 2009 10K.
There will be a proxy and the question is what will they ask us to vote for. Will it be for directors, auditors, bla, bla... or will it be for something major. Time will tell.
Renman, I think we must very soon see the proxy filing. The shareholder meeting is about a month away and there must be a min. amount of time necessary to get the information to the shareholders for a vote.
We now know that there will be a request for a shareholder vote via proxy or attendance at the meeting. The question is; what issues will we be asked to vote for?
There wouldn't be a vote for outstanding shares. The last thing you would want to see is a vote to increase the authorized shares (currently at a limit of 300 million). If you are correct in your assumption that Bill Quirk has exercised about 10 million of the 0.14 warrants and if we assume the others have expired, that would very positive in the sense that HDC would have north of five million cash and a potential dilution reduction of about 50 million shares.
Maythe warrants were exercised or did not expire there would have to be an 8K filing. If this is so, we might see something after the bell today which would be about a week after the event.
"On September 1, 2010, the Company’s board of directors (the “Board”) agreed to hold the annual meeting of shareholders on October 21, 2010 in Savannah, Georgia. The record date for the meeting is September 9, 2010."
"We will have a definitive answer on September 7th, 2010, and we will report the results of the warrant exercise shortly thereafter." Wonder how long this will take. Do they have to wait for the check to clear?
100K blocks starting to go throuth ;)
Adaptive website link:
http://www.adaptive.com/index.html
Impressive, unexpected and probably the fastest route to apply SVM in other fields of operation.
"I see significant revenue potential for Health Discovery Corporation by applying our patented, pattern recognition technology in the area of data management and data-mining for these large international companies and government agencies which are customers of Adaptive Inc.,"
From Manta: "Adaptive, Inc is a private company categorized under Prepackaged Software and located in Aliso Viejo, CA. Our records show it was established in 2009 and incorporated in Nevada. Current estimates show this company has an annual revenue of 2,400,000 and employs a staff of approximately 25."